ENRIC SALAS

Prof. Dr. ENRIC SALAS

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2020 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
CARMEN Martin Carreras-PresasCARMEN Martin Carreras-Presas
CARMEN Martin Carreras-Presas
JSJuan Amaro Sánchez
Juan Amaro Sánchez
ALAntonio Francisco López‐Sánchez
Antonio Francisco López‐Sánchez
ESENRIC SALAS
ENRIC SALAS
MPMaria Luisa Somacarrera Pérez
Maria Luisa Somacarrera Pérez

1 January 2017 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
MSM Seminario-Amez
M Seminario-Amez
JLJ Lopez-Lopez
J Lopez-Lopez
AEA Estrugo-Devesa
A Estrugo-Devesa
Raúl Ayuso‐MonteroRaúl Ayuso‐Montero
Raúl Ayuso‐Montero
ESENRIC SALAS
ENRIC SALAS
Probiotics are microorganisms, mainly bacteria, which benefit the host’s health. Many studies support the role of probiotics as a contributor to gastrointestinal health, and nowadays many authors are trying to prove its influence in oral health maintenance. To review the published literature with the purpose of knowing the importance of using probiotics as a preventive and therapeutic method for oral infectious diseases management. An electronic search in PubMed database with the keywords “oral health AND probiotics AND dentistry” was conducted. The inclusion criteria were: randomized clinical trials (RCTs) that assess the action of any probiotic strain in the treatment and / or prevention of an infectious oral disease, RCTs that assess the action of any probiotic strain on counting colony forming units (CFU) of oral pathogens, systematic reviews and meta-analysis. The Jadad scale was used to assess the high quality of RCTs. Fifteen articles were considered for this review. Of which, 12 were RCTs of good / high quality (Jadad scale), two meta-analysis and one systematic review. The literature reviewed suggests probiotics usage could be beneficial for the maintenance of oral health, due to its ability to decrease the colony forming units (CFU) counts of the oral pathogens. However, randomized clinical trials with long-term follow-up periods are needed to confirm their efficacy in reducing the prevalence/incidence of oral infectious diseases. Furthermore, the recognition of specific strains with probiotic activity for each infectious oral disease is required, in order to determine exact dose, treatment time and ideal vehicles. Key words:Probiotics, periodontal diseases, dental caries, oral health.

16 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
CSConstanza Saka-Herrán
Constanza Saka-Herrán
ESENRIC SALAS
ENRIC SALAS
ARantonio mari roig
antonio mari roig
AEAlbert Estrugo-Devesa
Albert Estrugo-Devesa
José López-LópezJosé López-López
José López-López
The purpose of this review was to identify and describe the causes that influence the time-intervals in the pathway of diagnosis and treatment of oral cancer and to assess its impact on prognosis and survival. The review was structured according to the recommendations of the Aarhus statement, considering original data from individual studies and systematic reviews that reported outcomes related to the patient, diagnostic and pre-treatment intervals. The patient interval is the major contributor to the total time-interval. Unawareness of signs and/or symptoms, denial and lack of knowledge about oral cancer are the major contributors to the process of seeking medical attention. The diagnostic interval is influenced by tumor factors, delays in referral due to higher number of consultations and previous treatment with different medicines or dental procedures and by professional factors such as experience and lack of knowledge related to the disease and diagnostic procedures. Patients with advanced stage disease, primary treatment with radiotherapy, treatment at an academic facility and transitions in care are associated with prolonged pre-treatment intervals. An emerging body of evidence supports the impact of prolonged pre-treatment and treatment intervals with poorer survival from oral cancer.

10 June 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
Elisabet Roca-MillanElisabet Roca-Millan
Elisabet Roca-Millan
AEAlbert Estrugo-Devesa
Albert Estrugo-Devesa
AMAlexandra Merlos
Alexandra Merlos
ESENRIC SALAS
ENRIC SALAS
TVTeresa Vinuesa
Teresa Vinuesa
José López-LópezJosé López-López
José López-López
Systemic antibiotics are routinely prescribed in implant procedures, but the lack of consensus causes large differences between clinicians regarding antibiotic prophylaxis regimens. The objectives of this systematic review are to assess the need to prescribe antibiotics to prevent early implant failure and find the most appropriate antibiotic prophylaxis regimen. The electronic search was conducted in PubMed/MEDLINE, Scielo and Cochrane Central Trials Database for randomized clinical trials of at least 3 months of follow-up. Eleven studies were included in the qualitative analysis. Antibiotics were found to statistically significantly reduce early implant failures (RR = 0.30, 95% CI: 0.19–0.47, p < 0.00001; heterogeneity I2 = 0%, p = 0.54). No differences were seen between preoperative or both pre- and postoperative antibiotic regimens (RR = 0.57, 95% CI: 0.21–1.55, p = 0.27; heterogeneity I2 = 0%, p = 0.37). A single preoperative antibiotic prophylaxis dose was found to be enough to significantly reduce early implant failures compared to no antibiotic (RR = 0.34, 95% CI: 0.21–0.53, p < 0.00001; heterogeneity I2 = 0%, p = 0.61). In conclusion, in healthy patients a single antibiotic prophylaxis dose is indicated to prevent early implant failure.

16 January 2022 in Materials
Verified
Journal Article
Open access
PDF file
Elisabet Roca-MillanElisabet Roca-Millan
Elisabet Roca-Millan
ESENRIC SALAS
ENRIC SALAS
ARantonio mari roig
antonio mari roig
ÁJÁlvaro Jiménez-Guerra
Álvaro Jiménez-Guerra
IOIvan Ortiz
Ivan Ortiz
LMLoreto Monsalve-Guil
Loreto Monsalve-Guil
The demand for synthetic graft materials in implant dentistry is rising. This systematic review aims to evaluate the survival rate of dental implants placed simultaneously with bone regeneration procedures using the material β-tricalcium phosphate, one of the most promising synthetic graft materials. The electronic search was conducted in PubMed, Scielo, and the Cochrane Central Register of Controlled Trials. Five randomized clinical trials, one non-randomized controlled clinical trial and four observational studies without control group were include. Implant survival rate and other clinical, radiographic, and histological parameters did not differ from those of implants placed simultaneously with another type of graft material, or placed in blood clots or natural alveolar ridges. Based on the available literature, β-tricalcium phosphate seems to be a promising graft material in implant dentistry. Nevertheless, more randomized clinical trials, with long follow-up periods, preoperative and postoperative CBCT, and histological analysis, are necessary to assess its long-term behavior.

15 March 2016 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
COCarlos Omaña-Cepeda
Carlos Omaña-Cepeda
AMAndrea Martínez-Valverde
Andrea Martínez-Valverde
MRMaría del Mar Sabater- Recolons
María del Mar Sabater- Recolons
ESENRIC SALAS
ENRIC SALAS
AMAntonio Marí-Roig
Antonio Marí-Roig
José López-LópezJosé López-López
José López-López
To report an uncommon case of hand, foot and mouth disease, (HFMD) in an immunocompetent adult; a highly infectious disease, characterized by the appearance of vesicles on the mouth, hands and feet, associated with coxsackieviruses and enteroviruses; including a literature review. A 23 year Caucasian male with no medical or surgical history, no allergies, was not taking any medication and smoked ten cigarettes a day, suffering from discomfort in the oral cavity; itching, burning and pain when swallowing associated with small erythematous lesions located on the hard palate, and small ulcers in tonsillar pillars and right buccal mucosa. Mild fever of 37.8 °C and general malaise. The patient reported he had had contact with a child diagnosed with HFMD. From his background and symptoms, the patient was diagnosed with HFMD. Following symptomatic treatment, the symptoms remitted in 7 days. A literature review in MEDLINE (PubMed). The inclusion criteria were for studies on humans over the last 5 years, using the keywords HFMD. We found 925 articles, which were subsequently reduced to 52 documents after applying the inclusion criteria. Maculopapular lesions were found on hands and feet. Dentists may have a key role diagnosing the disease. A surveillance system to predict future outbreaks, encourage early diagnosis, put appropriate public health measures in place and research vaccine development is vitally important in order to control the disease.